Tag: Enrollment

MorphoSys AG : MorphoSys Completes Enrollment of Phase 3 MANIFEST-2 Study of Pelabresib in Myelofibrosis with Topline Results Expected by End of 2023
Posted in MANIFESTATION

MorphoSys AG : MorphoSys Completes Enrollment of Part 3 MANIFEST-2 Examine of Pelabresib in Myelofibrosis with Topline Outcomes Anticipated by Finish of 2023

EQS-Information: MorphoSys AG / Key phrase(s): Miscellaneous MorphoSys Completes Enrollment of Part 3 MANIFEST-2 Examine of Pelabresib…

April 4, 2023 ZeroToHero
MorphoSys Completes Enrollment of Phase 3 MANIFEST-2 Study of Pelabresib in Myelofibrosis with Topline Results Expected by End of 2023
Posted in MANIFESTATION

MorphoSys Completes Enrollment of Section 3 MANIFEST-2 Examine of Pelabresib in Myelofibrosis with Topline Outcomes Anticipated by Finish of 2023

EQS-Information: MorphoSys AG / Key phrase(s): MiscellaneousMorphoSys Completes Enrollment of Section 3 MANIFEST-2 Examine of Pelabresib in…

April 4, 2023 ZeroToHero